Tomas Kiselak, Director, 10% Owner at Dianthus Therapeutics, Inc. /DE/ (DNTH), bought 48,508 shares at $11.76 ($543K) on 2023-09-13, disclosed to the SEC on 2023-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.85 | 14,887 | $162K | 29.7% |
| 2 | $10.85 | 14,887 | $162K | 29.7% |
| 3 | $11.76 | 9,367 | $110K | 20.3% |
| 4 | $11.76 | 9,367 | $110K | 20.3% |
| Total | $11.20 avg | 48,508 | $543K | 100% |
| Filing → |